Over 30 million acne patients seek treatment in the U.S. each year - - XYNGARI™ Phase 3 STAR-1 trial enrolled 520 patients with moderate-to-severe acne in the U.S. "We wish to thank the patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback